Dermatologist‐level classification of malignant lip diseases using a deep convolutional neural network
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Deep convolutional neural networks (DCNNs) can classify skin diseases at a level equivalent to a dermatologist, but their performance in specific areas requires further research. OBJECTIVE: To evaluate the performance of a trained DCNN-based algorithm in classifying benign and malignant lip diseases. METHODS: A training set of 1629 images (743 malignant, 886 benign) was used with Inception-Resnet-V2. Performance was evaluated using another set of 344 images and 281 images from other hospitals. Classifications by 44 participants (six board-certified dermatologists, 12 dermatology residents, nine medical doctors not specialized in dermatology and 17 medical students) were used for comparison. RESULTS: The outcomes based on the area under curve, sensitivity and specificity were 0·827 [95% confidence interval (CI) 0·782-0·873], 0·755 (95% CI 0·673-0·827) and 0·803 (95% CI 0·752-0·855), respectively, for the set of 344 images; and 0·774 (95% CI 0·699-0·849), 0·702 (95% CI 0·579-0·808) and 0·759 (95% CI 0·701-0·813), respectively, for the set of 281 images. The DCNN was equivalent to the dermatologists and superior to the nondermatologists in classifying malignancy. After referencing the DCNN result, the mean ± SD Youden index increased significantly for nondermatologists, from 0·201 ± 0·156 to 0·322 ± 0·141 (P < 0·001). CONCLUSIONS: DCNNs can classify lip diseases at a level similar to dermatologists. This will help unskilled physicians discriminate between benign and malignant lip diseases. What's already known about this topic? Deep convolutional neural networks (DCNNs) can classify malignant and benign skin diseases at a level equivalent to dermatologists. The lips are a unique feature in terms of histology and morphology. Previous studies of DCNNs have not investigated tumours on specific locations. What does this study add? This study shows that DCNNs can distinguish rare malignant and benign lip disorders at the same rate as dermatologists. DCNNs can help nondermatologists to distinguish malignant lip diseases. What are the clinical implications of this work? DCNNs can distinguish malignant and benign skin diseases even at specific locations such as the lips, as well as board-certified dermatologists. Malignant lip diseases are rare and difficult for less trained doctors to differentiate them from benign lesions. This study shows that in dermatology, DCNN can help improve decision-making processes for rare skin diseases in specific areas of the body.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Convolutional neural networks: an overview and application in radiology
Yamashita, R., Nishio, M., Do, R. K. G., & Togashi, K. (2018) · Insights into Imaging · doi:10.1007/s13244-018-0639-9 · Cited by 4,682 · cited 1×
“36 This study has certain limitations.”
Benchmark analysis of representative deep neural network architectures
Bianco, S., Cadene, R., Celona, L., & Napoletano, P. (2018) · IEEE Access · doi:10.1109/access.2018.2877890 · Cited by 838
Machine Learning and Health Care Disparities in Dermatology
Adamson, A. S., & Smith, A. (2018) · JAMA Dermatology · doi:10.1001/jamadermatol.2018.2348 · Cited by 639
Han, S. S., Park, G. H., Lim, W., Kim, M. S., Na, J. I., Park, I., & Chang, S. E. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191493 · Cited by 305 · cited 1×
“16,23 However, to date, there have been no studies that separate malignant and benign skin lesion on specific areas such as the lips, scalp or genitalia.”
Background
Cited by
Machine Learning in Dermatology: Current Applications, Opportunities, and Limitations
Chan, S., Reddy, V., Myers, B., Thibodeaux, Q., Brownstone, N., & Liao, W. (2020) · Dermatology and Therapy · doi:10.1007/s13555-020-00372-0 · Cited by 267
Artificial Intelligence in Dermatology: A Primer
Young, A. T., Xiong, M., Pfau, J., Keiser, M. J., & Wei, M. L. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.02.026 · Cited by 249
Han, S. S., Park, I., Eun Chang, S., Lim, W., Kim, M. S., Park, G. H., Chae, J. B., Huh, C. H., & Na, J.-I. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.01.019 · Cited by 248
Deep learning in dermatology: a systematic review of current approaches, outcomes, and limitations
Jeong, H. K., Park, C., Henao, R., & Kheterpal, M. (2023) · JID Innovations · doi:10.1016/j.xjidi.2022.100150 · Cited by 134
Human-AI interaction in skin cancer diagnosis: a systematic review and meta-analysis
Krakowski, I., Kim, J., Cai, Z. R., Daneshjou, R., Lapins, J., Eriksson, H., Lykou, A., & Linos, E. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01031-w · Cited by 87
Metadata
- Authors
- Cho, S. I., Sun, S., Mun, J. ‐., Kim, C., Kim, S. Y., Cho, S., Youn, S. W., Kim, H. C., & Chung, J. H.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-11-19
- Volume
- 182
- Issue
- 6
- Pages
- 1388-1394
- ISSN
- 0007-0963 (ISSN-L)
- 1365-2133
- OpenAlex
- W2970233898
- Cited by
- 58
- References
- 5
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.